Home > Cashflow Statement > MARKSANS PHARMA

MARKSANS PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Financing Activities ₹-71 Cr₹-65 Cr₹-69 Cr₹198 Cr₹80 Cr

What is the latest Cash Flow from Financing Activities ratio of MARKSANS PHARMA ?

The latest Cash Flow from Financing Activities ratio of MARKSANS PHARMA is ₹-71 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Financing Activities
Mar2026₹-71 Cr
Mar2025₹-65 Cr
Mar2024₹-69 Cr
Mar2023₹198 Cr
Mar2022₹80 Cr

How is Cash Flow from Financing Activities of MARKSANS PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2026 ₹-71 Cr
Negative
Mar2025 ₹-65 Cr
Negative
Mar2024 ₹-69 Cr
Negative
Mar2023 ₹198 Cr
148.81
Mar2022 ₹80 Cr -

Compare Cash Flow from Financing Activities of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹14,343.8 Cr -4.2% -4.6% 76.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹444,717.0 Cr -0.8% -1.5% 15.1% Stock Analytics
DIVIS LABORATORIES ₹244,223.0 Cr -3% 8.3% 52.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹183,453.0 Cr -2.2% -1.5% 35% Stock Analytics
CIPLA ₹109,849.0 Cr -0.6% -4.9% -13% Stock Analytics
DR REDDYS LABORATORIES ₹95,591.8 Cr 0.2% -3.9% -11.8% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-4.2%

-4.6%

76.8%

SENSEX

-1.6%

-4.7%

-8.3%


You may also like the below Video Courses